Aprea Therapeutics, Inc. (APRE) stock
APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.45+0.05 (+11.52%)
Close on Nov 17, 2026Market cap $5.71MP/E –Yield –
Aprea Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Aprea Therapeutics's enterprise value was -$35.73M on Nov 11, 2026, against -$6.18M a year earlier. Over the last 5 years it ranged from -$39.04M to $9.96M, with a median of -$11.75M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$35.73M | – |
| 2025 | Dec 31, 2025 | -$8.62M | – |
| 2024 | Dec 31, 2024 | -$8.37M | – |
| 2023 | Dec 29, 2023 | -$7.79M | – |
| 2022 | Dec 30, 2022 | -$15.82M | – |
| 2021 | Dec 31, 2021 | -$124.80K | -104.0% |
| 2020 | Dec 31, 2020 | $3.09M | +63.1% |
| 2019 | Dec 31, 2019 | $1.90M | – |
See a number that looks wrong?